LAHORE: The Lahore High Court (LHC) restrained the Punjab government from proceeding further on a purchase order for supply of insulin to public hospitals and sought replies from the respondents.

Justice Ayesha A. Malik issued a stay on a petition by the Getz Pharmaceutical Company, challenging the change of conditions for the tender after shortlisting process.

Advocate Raheel Kamran Sheikh, the counsel for the company, argued that the respondent authorities had imposed the condition of providing biosimilarity studies in the technical specification of the tender for drugs/medicines and medical devices. He alleged that the requirement of biosimilarity studies had not been provided for in the rules and it was a condition catered specifically to enable a respondent pharma company, namely Novo Nordisk Pharma, to participate and succeed in the bidding process.

The counsel argued that the condition was tailor made to exclude the petitioner/company as the respondent/company was the sole agent for a foreign supplier that might have the capacity to provide biosimilarity studies for the product. He said the impugned condition eliminated the opportunity of fair competition.

The counsel pointed out that the petitioner agitated the matter before the government, which failed to decide the same in accordance with law.

Additional Advocate General Akhtar Javed, on behalf of the government, questioned the maintainability of the petition before the court. He said the petitioner had participated in the tendering process and resorted to litigation after the purchase order was issued to the respondent company.

The written order issued on Monday about Friday’s hearing on the petition said, “The respondents are restrained from proceeding further in the matter that is proceedings on the basis of the purchase order until next date of hearing.”

The judge also directed the respondents to submit their reports and parawise comments by Feb 17. The respondents also include the secretary health, director general health services and the Punjab Procurement Regulatory Authority.

Published in Dawn, February 11th, 2020

Opinion

Editorial

Last call
Updated 15 Nov, 2024

Last call

PTI should hardly be turning its "final" protest into a "do or die" occasion.
Mini budget talk
15 Nov, 2024

Mini budget talk

NO matter how much Pakistan’s finance managers try to downplay the prospect of a ‘mini budget’ to pull off a...
Diabetes challenge
15 Nov, 2024

Diabetes challenge

AMONGST the many public health challenges confronting Pakistan, diabetes arguably does not get the attention it...
China security ties
Updated 14 Nov, 2024

China security ties

If China's security concerns aren't addressed satisfactorily, it may affect bilateral ties. CT cooperation should be pursued instead of having foreign forces here.
Steep price
14 Nov, 2024

Steep price

THE Hindu Kush-Himalayan region is in big trouble. A new study unveiled at the ongoing COP29 reveals that if high...
A high-cost plan
14 Nov, 2024

A high-cost plan

THE government has approved an expensive plan for FBR in the hope of tackling its deep-seated inefficiencies. The...